CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


HP:0001342: Cerebral hemorrhageHPO

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug713 Colorectal resection Wiki 1.00

Correlated MeSH Terms (8)


Name (Synonyms) Correlation
D013226 Status Epilepticus NIH 1.00
D002543 Cerebral Hemorrhage NIH 1.00
D013345 Subarachnoid Hemorrhage NIH 1.00
D006470 Hemorrhage NIH 0.50
D000070642 Brain Injuries, Traumatic NIH 0.38
D001930 Brain Injuries, NIH 0.33
D020521 Stroke NIH 0.29
D014947 Wounds and Injuries NIH 0.19

Correlated HPO Terms (3)


Name (Synonyms) Correlation
HP:0002133 Status epilepticus HPO 1.00
HP:0002138 Subarachnoid hemorrhage HPO 1.00
HP:0001297 Stroke HPO 0.29

There is one clinical trial.

Clinical Trials


1 Severe Neurologic Injury Outcomes During COVID-19 Crisis

A prospective cohort minimal risk study to determine the impact of the COVID-19 crisis on outcomes of neurologically injured ICU patients.

NCT04496076 Sars-CoV2 Severe Neurologic Injury Ischemic Stroke Hemorrhagic Stroke Intracerebral Hemorrhage Subarachnoid Hemorrhage Traumatic Brain Injury Status Epilepticus
MeSH:Stroke Brain Injuries Brain Injuries, Traumatic Subarachnoid Hemorrhage Cerebral Hemorrhage Status Epilepticus Hemorrhage Wounds and Injuries
HPO:Cerebral hemorrhage Status epilepticus Stroke Subarachnoid hemorrhage

Primary Outcomes

Measure: In-hospital Mortality

Time: At hospital discharge, approximately 1 month

Measure: 30-day mortality

Time: 30 days post-hospital discharge

Secondary Outcomes

Description: Care treatment such as ventilator use, intubation, and/or tracheostomy

Measure: Limitations of patient care- Frequency of care not being provided

Time: During In-hospital course, up to 1 month

Measure: Limitations of patient care- Conversion of DNR/DNI/CMO status

Time: During In-hospital course, up to 1 month


HPO Nodes